Lindsey Baden, MD

Lindsey Baden is vice president of Clinical Research for Brigham and Women’s Hospital (BWH) and faculty lead of Connector at Harvard Catalyst. Additionally, he oversees the Center for Clinical Investigation at BWH and is a professor at Harvard Medical School. In his role as vice president, Baden provides comprehensive oversight of clinical research at BWH and is responsible for developing and implementing operational strategies. An infectious diseases specialist, Baden has served in several critical leadership roles, including directing the Infectious Diseases Immunocompromised Host program at BWH and Dana-Farber. He is deputy editor of The New England Journal of Medicine and has received continuous funding from the National Institutes of Health (NIH) throughout his career. Baden is an expert in developing new therapeutics and vaccines. In response to the COVID-19 crisis, he was integral in the design and conduct of the pivotal NIH co-sponsored vaccine efficacy trials and is the co-principal investigator for the phase 3 COVE study, which evaluated the mRNA-1273 (Moderna) vaccine candidate against COVID-19.